Zimmer Biomet Holdings, Inc.
ZBH
Ранг среди акций
#1244
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing... Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Цена акции
$95.27
Рыночная капитализация
$18.17B
Изменение (1 день)
-0.70%
Изменение (1 год)
-7.23%
Страна
US
Торговля Zimmer Biomet Holdings, Inc. (ZBH)
Категория
Healthcare
Выручка компании Zimmer Biomet Holdings, Inc. (ZBH)
Выручка на Jun 2026 TTM: $8.51B
Согласно последним финансовым отчетам Zimmer Biomet Holdings, Inc., текущая выручка компании (TTM) составляет $8.51B. В 2024 году компания получила выручку $7.68B больше, чем выручке в 2023 году, которая составила $7.39B. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Zimmer Biomet Holdings, Inc. с 2000 по 2026
Выручка на конец каждого года
| Год | Выручка | Изменить |
|---|---|---|
| 2026 (TTM) | $8.51B | 3.37% |
| 2025 | $8.23B | 7.20% |
| 2024 | $7.68B | 3.85% |
| 2023 | $7.39B | 6.55% |
| 2022 | $6.94B | 1.65% |
| 2021 | $6.83B | 11.42% |
| 2020 | $6.13B | -23.24% |
| 2019 | $7.98B | 0.62% |
| 2018 | $7.93B | 1.66% |
| 2017 | $7.80B | 1.76% |
| 2016 | $7.67B | 27.85% |
| 2015 | $6.00B | 28.34% |
| 2014 | $4.67B | 1.08% |
| 2013 | $4.62B | 3.39% |
| 2012 | $4.47B | 0.45% |
| 2011 | $4.45B | 5.49% |
| 2010 | $4.22B | 3.05% |
| 2009 | $4.10B | -0.62% |
| 2008 | $4.12B | 5.74% |
| 2007 | $3.90B | 11.50% |
| 2006 | $3.50B | 6.37% |
| 2005 | $3.29B | 10.24% |
| 2004 | $2.98B | 56.81% |
| 2003 | $1.90B | 38.52% |
| 2002 | $1.37B | 16.44% |
| 2001 | $1.18B | 13.26% |
| 2000 | $1.04B | 0.00% |
Выручка аналогичных компаний или конкурентов
| Компания | Выручка | Разница в выручке | Страна |
|---|---|---|---|
| $46.59B | 447.49% |
US
|
|
| $35.48B | 317.02% |
IE
|
|
| $25.84B | 203.65% |
US
|
|
| $21.00B | 146.75% |
US
|
|
| - | - |
DE
|
